Come On, We Had the Vaccine the Whole Time

You may be surprised to learn that of the trio of long-awaited coronavirus vaccines, the most promising, Moderna's mRNA-1273, which reported a 94.5 percent efficacy rate on November 16, had been designed by January 13. Read Full Article »


Comment
Show comments Hide Comments


Related Articles

Market Overview
Search Stock Quotes